Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 14, 2012

Drug Name Review Type Class Manufacturer
Juvisync New Drug Initial Review Diabetes/Cholesterol Merck and Co. Inc
Eylea New Drug Initial Review VEGF Inhibitor Regeneron
Pedipirox-4 Nail Kit New Drug Initial Review Antifungal � Topical Pedinol
Complera New Drug Appeal HIV Gilead
Natroba New Drug Appeal Pediculicide ParaPRO, LLC